Literature DB >> 4851712

Effect of verapamil in obstructive airways disease.

T Ringqvist.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4851712     DOI: 10.1007/bf00614392

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  34 in total

1.  [ISOPTIN (D-365), CLINICAL STUDIES ON THE TREATMENT OF CORONARY HEART DISEASE].

Authors:  B STRAESSLE; D BURCKHARDT
Journal:  Schweiz Med Wochenschr       Date:  1965-05-15

2.  CORONARY VASODILATORY AND CARDIAC ADRENERGIC BLOCKING EFFECTS OF IPROVERATRIL.

Authors:  K I MELVILLE; B G BENFEY
Journal:  Can J Physiol Pharmacol       Date:  1965-03       Impact factor: 2.273

3.  A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.

Authors:  J R Schmid; C Hanna
Journal:  J Pharmacol Exp Ther       Date:  1967-05       Impact factor: 4.030

4.  The ventilatory capacity in healthy subjects. An analysis of causal factors with special reference to the respiratory forces.

Authors:  T Ringqvist
Journal:  Scand J Clin Lab Invest Suppl       Date:  1966

5.  [The treatment of heart arrhythmia with the heart sympatholytic iproveratril].

Authors:  R Barousch
Journal:  Wien Klin Wochenschr       Date:  1967-11-17       Impact factor: 1.704

6.  Effect of a selectivebeta-adrenergic blocker in preventing falls in arterial oxygen tension following isoprenaline in asthmatic subjects.

Authors:  K N Palmer; W F Hamilton; J S Lge; M L Diament
Journal:  Lancet       Date:  1969-11-22       Impact factor: 79.321

7.  [The antiarrhythmic and coronary-dilating properties of verapamil in patients ith ischemic heart disease].

Authors:  B E Votcal; L G Lozinskij; V A Goldberg; M G Venediktova; O A Gribova
Journal:  Arzneimittelforschung       Date:  1970-09

8.  [The effect of iproveratril on angina pectoris and thef adrenergic beta-receptors of man].

Authors:  M Kaltenbach; D Zimmermann
Journal:  Dtsch Med Wochenschr       Date:  1968-01-05       Impact factor: 0.628

9.  [Treatment of tachycardiac arrhythmias and arterial hypertension with verapamil].

Authors:  F Bender
Journal:  Arzneimittelforschung       Date:  1970-09

10.  Effects of beta-adrenergic receptor blockade on airway conductance and lung volume in normal and asthmatic subjects.

Authors:  P S Richardson; G M Sterling
Journal:  Br Med J       Date:  1969-07-19
View more
  3 in total

Review 1.  Calcium channel blockers and asthma.

Authors:  S Y So; M Ip; W K Lam
Journal:  Lung       Date:  1986       Impact factor: 2.584

Review 2.  Heterogeneity of calcium channels in mast cells and basophils and the possible relevance to pathophysiology of lung diseases: a review.

Authors:  N Chand; J L Perhach; W Diamantis; R D Sofia
Journal:  Agents Actions       Date:  1986-03

Review 3.  Clinical use of verapamil.

Authors:  J K Vohra
Journal:  Drugs       Date:  1977-03       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.